Synergy Innovation Co., Ltd.
Financials
Valuation Metrics
Synergy Innovation Co., Ltd.'s Market Cap is ₩1196B. At end of 2025 it was ₩2066B. Ranked #1113 of 2,405 in KR market (top 46%), #578 of 1,627 on KOSDAQ (top 36%), #40 of 94 in Health Care Equipment & Services (top 43%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 119.65B KRW | KR#1,113/2,405 Sec#40/94 |
| Revenue | 116.56B KRW | KR#1,331/2,405 Sec#27/94 |
| Net Income | 18.54B KRW | KR#729/2,405 Sec#18/94 |
| Total Assets | 345.29B KRW | KR#957/2,405 Sec#18/94 |
| Net Assets | 282.74B KRW | KR#742/2,405 Sec#14/94 |
| Employees | 69 | KR#1,881/2,405 Sec#76/94 |
| Value | ||
| P/E | 6.45x | KR#566/2,405 Sec#13/94 |
| P/B | 0.42x | KR#709/2,405 Sec#9/94 |
| PEG | 0.03x | KR#245/2,405 Sec#12/94 |
| P/S | 1.03x | KR#1,451/2,405 Sec#29/94 |
| EV/EBITDA | 5.13x | KR#280/2,405 Sec#10/94 |
| FCF Yield | 7.86% | KR#728/2,405 Sec#19/94 |
| Profitability | ||
| ROE | 6.56% | KR#928/2,405 Sec#37/94 |
| ROA | 5.37% | KR#693/2,405 Sec#31/94 |
| Op. Margin | 16.20% | KR#260/2,405 Sec#21/94 |
| Revenue Growth | 16.45% | KR#636/2,405 Sec#35/94 |
| Earnings Growth | 228.03% | KR#220/2,405 Sec#11/94 |
| Financial Health | ||
| Debt Ratio | 22.12% | KR#416/2,405 Sec#23/94 |
| Total Debt | 22.37B KRW | KR#1,333/2,405 Sec#37/94 |
| FCF | 9.41B KRW | KR#723/2,405 Sec#17/94 |
| Cash | 45.14B KRW | KR#786/2,405 Sec#17/94 |
| Current Ratio | 4.19x | KR#354/2,405 Sec#25/94 |
| Net Debt/EBITDA | -1.21x | KR#336/2,405 Sec#12/94 |
| Dividend | ||
| Div. Yield | 4.14% | KR#450/2,405 Sec#3/94 |
| Div. Growth | 25.73% | KR#386/2,405 Sec#15/94 |
| Performance | ||
| 1Y Return | -44.23% | KR#1,836/2,405 Sec#62/94 |
| 1M Return | -15.02% | KR#1,583/2,405 Sec#64/94 |
| From 52W High | -47.87% | KR#1,068/2,405 Sec#37/94 |
| 1Y MDD | -47.42% | KR#842/2,405 Sec#30/94 |
| Trading | ||
| Volume | 211,291 shares | KR#353/2,405 Sec#13/94 |
| Trading Value | 288.2M KRW | KR#992/2,405 Sec#31/94 |
| Foreign Own. | 14.23% | KR#337/2,405 Sec#9/94 |
| Per Share | ||
| EPS | 210 KRW | KR#1,266/2,405 Sec#39/94 |
| BPS | 3,209 KRW | KR#1,821/2,405 Sec#55/94 |
Company Info
Synergy Innovation, established in 1998 and listed on KOSDAQ in 2004, is a specialized microorganism culture media manufacturing company with five subsidiaries. It operates biotechnology, medical, and health functional food businesses, including investing in new drug development for brain and central nervous system diseases through Neurobiogen. The company produces in-vitro diagnostic and environmental monitoring products in ISO13485 and KGMP-certified environments, focusing on manufacturing facility expansion and production automation from 2024, from its headquarters in Seongnam-si, Gyeonggi-do.